Overview

Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle

Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
This study has two protocols the aims of which are: 1. To identify age-related effects of AA on incretin secretion and whether and to what extent AA exhibit a true incretin effect (gut- mediated increases in plasma insulin) in younger individuals. (Protocol 1) 2. To define the extra-pancreatic ''novel'', insulin independent effects of glucagon like peptide-1 (GLP-1) on postprandial muscle protein and glucose metabolism and microvascular blood flow. (Protocol 2)
Phase:
N/A
Details
Lead Sponsor:
University of Nottingham
Treatments:
Glucagon
Glucagon-Like Peptide 1
Incretins
Insulin
Insulin, Globin Zinc